Consolidation of the Americas and Other Label Business
First written in FY2020-Q1. 2 of 7 entries say "Restated". Latest entry: FY2022-Q3.
No other company in this theme has enough history to compare yet.
- FY2022-Q3RestatedAnnual report
「For the product categories, "Contract Packaging for Pharmaceuticals and Other Products" in the Japan segment has been changed to "Other," and "Other Label" in the Americas segment has been changed to "Other," in each case from the previous category. The comparisons below with the same period of the previous year are based on figures reclassified into the revised segment and product categories.」
The revised product category, under which the Americas Other Label business is classified as "Other," and the reclassification of the figures for the same period of the previous year continue to be applied. - FY2022-Q1ReframedAnnual report
「For the product categories, "Contract Packaging for Pharmaceuticals and Other Products" in the Japan segment has been changed to "Other," and "Other Label" in the Americas segment has been changed to "Other," in each case from the previous category. The comparisons below with the same period of the previous year are based on figures reclassified into the revised segment and product categories.」
The Americas Other Label business was reclassified under the product category "Other," and the figures for the same period of the previous year were also reclassified for comparison. - FY2021-Q3Other Label sales continue to exceed the previous yearAnnual report
「Other Label sales were ¥1,133 million, up 26.0% year on year and up 27.8% on a local-currency basis.」
Although a policy of selectively accepting orders in preparation for reducing the scale of the Americas Other Label business had been indicated, sales for the nine months ended the third quarter increased 26.0% year on year. - FY2021-Q2Other Label sales exceed the previous yearAnnual report
「Other Label sales were ¥748 million, up 31.1% year on year and up 33.4% on a local-currency basis.」
Although a policy of reducing the scale of the Americas Other Label business had been indicated, sales for the first half increased 31.1% year on year. - FY2020-Q3RestatedAnnual report
「Shrink-label sales exceeded the previous year. Other Label sales fell below the previous year because orders were selectively accepted in preparation for reducing the scale of the business.」
In the Americas Other Label business, the policy of selectively accepting orders in preparation for reducing the scale of the business remains in effect. - FY2020-Q2AdvancedAnnual report
「Shrink-label sales exceeded the previous year. Other Label sales fell below the previous year because orders were selectively accepted in preparation for reducing the scale of the business, while machinery sales recognition shifted to the third quarter onward.」
In the Americas Other Label business, the company implemented specific initiatives to selectively accept orders in preparation for reducing the scale of the business. - FY2020-Q1First statedAnnual report
「In terms of profit and loss, operating profit was ¥874 million, down 20.2% year on year and down 21.7% on a local-currency basis, due in part to initiatives to consolidate the Other Label business.」
In the Americas, the company has for the first time explicitly stated that it is pursuing initiatives to consolidate the Other Label business.